A citation-based method for searching scientific literature

Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
Times Cited: 258







List of shared articles



Times cited

Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
Mila Gugnoni, Veronica Manicardi, Federica Torricelli, Elisabetta Sauta, Riccardo Bellazzi, Gloria Manzotti, Emanuele Vitale, Dario de Biase, Simonetta Piana, Alessia Ciarrocchi. Thyroid 2021
10

A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
Sounak Gupta, Chad M Vanderbilt, Yun-Te Lin, Jamal K Benhamida, Achim A Jungbluth, Satshil Rana, Amir Momeni-Boroujeni, Jason C Chang, Tiffany Mcfarlane, Paulo Salazar,[...]. J Mol Diagn 2021
3

SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.
Mahesh Saqcena, Luis Javier Leandro-Garcia, Jesper L V Maag, Vatche Tchekmedyian, Gnana P Krishnamoorthy, Prasanna P Tamarapu, Vera Tiedje, Vincent Reuter, Jeffrey A Knauf, Elisa de Stanchina,[...]. Cancer Discov 2021
3

[Diagnostic principles of thyroid tumors in pathology : Relevant changes due to the current WHO classification].
Sarah Theurer, Josefine Rawitzer, Saskia Ting, Kurt Werner Schmid. Pathologe 2021
1


Arms-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers With Worse Prognosis Determined by Coexisting BRAF V600E and Tert Promoter Mutations.
Peng-Cheng Yu, Li-Cheng Tan, Xiao-Li Zhu, Xiao Shi, Roman Chernikov, Arseny Semenov, Ling Zhang, Ben Ma, Yu Wang, Xiao-Yan Zhou,[...]. Endocr Pract 2021
2

Molecular-Driven Therapy in Advanced Thyroid Cancer.
Kevin C Miller, Ashish V Chintakuntlawar. Curr Treat Options Oncol 2021
0

Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.
Jinwei Hu, Isabella J Yuan, Saied Mirshahidi, Alfred Simental, Steve C Lee, Xiangpeng Yuan. Int J Mol Sci 2021
2

Advances in Detecting Low Prevalence Somatic TERT Promoter Mutations in Papillary Thyroid Carcinoma.
Vitor Rodrigues da Costa, Larissa Valdemarin Bim, Luiza Dornelles Penteado Pacheco E Silva, Gabriel Avelar Colloza-Gama, André Uchimura Bastos, Rosana Delcelo, Gisele Oler, Janete Maria Cerutti. Front Endocrinol (Lausanne) 2021
0

Molecular pathogenesis of pediatric thyroid carcinoma.
Norisato Mitsutake, Vladimir Saenko. J Radiat Res 2021
1

Immune Landscape of Thyroid Cancers: New Insights.
Elisa Menicali, Martina Guzzetti, Silvia Morelli, Sonia Moretti, Efisio Puxeddu. Front Endocrinol (Lausanne) 2021
0

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation - association or random chance?
Klara Johansson, Adam Stenman, Johan O Paulsson, Na Wang, Catharina Ihre-Lundgren, Jan Zedenius, C Christofer Juhlin. Thyroid Res 2021
0


Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.
Cristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano, Ángel M Martínez-Montes, Eduardo Zarzuela, Javier Muñoz, Rafael Torres-Perez, Guillermo Pita, Alfonso Cordero-Barreal, Luis J Leandro-García,[...]. Int J Cancer 2020
10

Incremental utility of expanded mutation panel when used in combination with microRNA classification in indeterminate thyroid nodules.
Sara Jackson, Gyanendra Kumar, Anna B Banizs, Nicole Toney, Jan F Silverman, Christina M Narick, Sydney D Finkelstein. Diagn Cytopathol 2020
9

Molecular therapeutics for anaplastic thyroid cancer.
Nikita Pozdeyev, Madison M Rose, Daniel W Bowles, Rebecca E Schweppe. Semin Cancer Biol 2020
10

Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort.
Haixia Guan, Gianluca Toraldo, Sandra Cerda, Frederick A Godley, Sowmya R Rao, David McAneny, Gerard Doherty, Lewis Braverman, Stephanie L Lee. Thyroid 2020
15

Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance.
Laura Fugazzola, Marina Muzza, Gabriele Pogliaghi, Mario Vitale. Cancers (Basel) 2020
15

Clinical and Translational Challenges in Thyroid Cancer.
Jorge Hernando, Javier Ros, Alvaro Arroyo, Jaume Capdevila. Curr Med Chem 2020
3

Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.
Leila J Mady, Michael C Grimes, Nayel I Khan, R Harsha Rao, Simion I Chiosea, Linwah Yip, Robert L Ferris, Yuri E Nikiforov, Sally E Carty, Umamaheswar Duvvuri. Sci Rep 2020
2

Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel.
Ali S Alzahrani, Meshael Alswailem, Anwar Ali Alswailem, Hindi Al-Hindi, Ewa Goljan, Nourah Alsudairy, Mohamed Abouelhoda. J Clin Endocrinol Metab 2020
8

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma.
Dagmara Rusinek, Aleksandra Pfeifer, Marta Cieslicka, Malgorzata Kowalska, Agnieszka Pawlaczek, Jolanta Krajewska, Sylwia Szpak-Ulczok, Tomasz Tyszkiewicz, Monika Halczok, Agnieszka Czarniecka,[...]. Cancers (Basel) 2020
6

Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations.
Naoki Oishi, Huy Gia Vuong, Kunio Mochizuki, Tetsuo Kondo. Endocr Pathol 2020
2


Late-onset distant metastases confer poor prognosis in patients with well-differentiated thyroid cancer.
Chan Kwon Jung, Sohee Lee, Ja Seong Bae, Dong-Jun Lim. Gland Surg 2020
0

The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Ling Zhao, Lin Wang, Xiaomeng Jia, Xiaodong Hu, Ping Pang, Sitong Zhao, Yajing Wang, Jing Wang, Yingshi Zhang, Zhaohui Lyu. Front Oncol 2020
3

T-Box Transcription Factor 22 Is an Immune Microenvironment-Related Biomarker Associated With the BRAF V600E Mutation in Papillary Thyroid Carcinoma.
Xubin Dong, Jingjing Song, Jing Hu, Cheng Zheng, Xiaohua Zhang, Haiguang Liu. Front Cell Dev Biol 2020
1

Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer.
Shikha Saini, Ajay V Maker, Kenneth D Burman, Bellur S Prabhakar. Biochim Biophys Acta Rev Cancer 2019
3

Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules.
Shikha Bose, Wendy Sacks, Ann E Walts. Adv Anat Pathol 2019
9

Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
18

Coding Molecular Determinants of Thyroid Cancer Development and Progression.
Veronica Valvo, Carmelo Nucera. Endocrinol Metab Clin North Am 2019
7

Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
Ian Ganly, David G McFadden. Thyroid 2019
17

Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.
Dilmi Perera, Ronald Ghossein, Niedzica Camacho, Yasin Senbabaoglu, Venkatraman Seshan, Juan Li, Nancy Bouvier, Laura Boucai, Agnes Viale, Nicholas D Socci,[...]. J Clin Endocrinol Metab 2019
8


Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.
Jessica D Kondraciuk, Samuel L Rice, Xiaosun Zhou, Karem Gharzeddine, Andrea Knezevic, Daniel E Spratt, Mona Sabra, Steven M Larson, Ravinder K Grewal, Joseph R Osborne. Clin Nucl Med 2019
4

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
56

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
Federica Panebianco, Alyaksandr V Nikitski, Marina N Nikiforova, Yuri E Nikiforov. Cancer Med 2019
17

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry.
Ana P Estrada-Flórez, Mabel E Bohórquez, Alejandro Vélez, Carlos S Duque, Jorge H Donado, Gilbert Mateus, Cesar Panqueba-Tarazona, Guadalupe Polanco-Echeverry, Ruta Sahasrabudhe, Magdalena Echeverry,[...]. Endocr Connect 2019
4

Molecular Alterations in Thyroid Carcinoma.
Mohamed Rizwan Haroon Al Rasheed, Bin Xu. Surg Pathol Clin 2019
10

Genomic Hallmarks of Thyroid Neoplasia.
Thomas J Giordano. Annu Rev Pathol 2018
25

Long noncoding RNAs: emerging players in thyroid cancer pathogenesis.
Avaniyapuram Kannan Murugan, Arasambattu Kannan Munirajan, Ali S Alzahrani. Endocr Relat Cancer 2018
82

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Giorgia Acquaviva, Michela Visani, Andrea Repaci, Kerry J Rhoden, Dario de Biase, Annalisa Pession, Tallini Giovanni. Histopathology 2018
52

Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules.
Michiya Nishino, Marina Nikiforova. Arch Pathol Lab Med 2018
40